• Something wrong with this record ?

Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management

LR. Olde Nordkamp, TF. Brouwer, C. Barr, DA. Theuns, LV. Boersma, JB. Johansen, P. Neuzil, AA. Wilde, N. Carter, M. Husby, PD. Lambiase, RE. Knops,

. 2015 ; 195 (-) : 126-33. [pub] 20150522

Language English Country Netherlands

Document type Clinical Trial, Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16010142

BACKGROUND: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the need for transvenous leads, and therefore has the potential to improve lead-longevity and reduce lead-related complications. The S-ICD has a morphology-based sensing algorithm of which inappropriate shocks have been reported. METHODS: We analyzed the incidence, predictors and management of inappropriate shocks in the EFFORTLESS S-ICD Registry, which collects S-ICD implantation information and follow-up data from clinical centers in Europe and New Zealand. RESULTS: During a follow-up of 21 ± 13 months, 48 out of 581 S-ICD patients (71% male, age 49 ± 18 years) experienced 101 inappropriate shocks (8.3%). The most common cause was cardiac signal oversensing (73%), such as T-wave oversensing. Eighteen shocks (18%) were due to supraventricular tachycardias (SVT), of which 15 occurred in the shock-only zone. Cox-proportional hazard modeling using time-dependent covariates demonstrated that patients with a history of atrial fibrillation (HR 2.4) and patients with hypertrophic cardiomyopathy (HR 4.6) had an increased risk for inappropriate shocks, while programming the primary vector for sensing (from xyphoid to V6) reduced the risk. Reprogramming or optimization of SVT treatment after the first clinical event of inappropriate shock was successful in preventing further inappropriate shocks for cardiac oversensing and SVT events. CONCLUSIONS: Inappropriate shocks, mainly due to cardiac oversensing, occurred in 8.3% of the S-ICD patients. Patients with hypertrophic cardiomyopathy or a history of atrial fibrillation were at increased risk, warranting specific attention for sensing and programming in this population.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010142
003      
CZ-PrNML
005      
20160414110207.0
007      
ta
008      
160408s2015 ne f 000 0|engg|
009      
AR
024    7_
$a 10.1016/j.ijcard.2015.05.135 $2 doi
024    7_
$a 10.1016/j.ijcard.2015.05.135 $2 doi
035    __
$a (PubMed)26026928
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Olde Nordkamp, Louise R A $u Academic Medical Center, Amsterdam, Netherlands.
245    10
$a Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management / $c LR. Olde Nordkamp, TF. Brouwer, C. Barr, DA. Theuns, LV. Boersma, JB. Johansen, P. Neuzil, AA. Wilde, N. Carter, M. Husby, PD. Lambiase, RE. Knops,
520    9_
$a BACKGROUND: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the need for transvenous leads, and therefore has the potential to improve lead-longevity and reduce lead-related complications. The S-ICD has a morphology-based sensing algorithm of which inappropriate shocks have been reported. METHODS: We analyzed the incidence, predictors and management of inappropriate shocks in the EFFORTLESS S-ICD Registry, which collects S-ICD implantation information and follow-up data from clinical centers in Europe and New Zealand. RESULTS: During a follow-up of 21 ± 13 months, 48 out of 581 S-ICD patients (71% male, age 49 ± 18 years) experienced 101 inappropriate shocks (8.3%). The most common cause was cardiac signal oversensing (73%), such as T-wave oversensing. Eighteen shocks (18%) were due to supraventricular tachycardias (SVT), of which 15 occurred in the shock-only zone. Cox-proportional hazard modeling using time-dependent covariates demonstrated that patients with a history of atrial fibrillation (HR 2.4) and patients with hypertrophic cardiomyopathy (HR 4.6) had an increased risk for inappropriate shocks, while programming the primary vector for sensing (from xyphoid to V6) reduced the risk. Reprogramming or optimization of SVT treatment after the first clinical event of inappropriate shock was successful in preventing further inappropriate shocks for cardiac oversensing and SVT events. CONCLUSIONS: Inappropriate shocks, mainly due to cardiac oversensing, occurred in 8.3% of the S-ICD patients. Patients with hypertrophic cardiomyopathy or a history of atrial fibrillation were at increased risk, warranting specific attention for sensing and programming in this population.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a fibrilace síní $x epidemiologie $7 D001281
650    _2
$a hypertrofická kardiomyopatie $x epidemiologie $7 D002312
650    12
$a defibrilátory implantabilní $x škodlivé účinky $x normy $7 D017147
650    12
$a elektrická defibrilace $x škodlivé účinky $x metody $7 D004554
650    _2
$a analýza selhání vybavení $x statistika a číselné údaje $7 D019544
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a zlepšení kvality $7 D058996
650    _2
$a rizikové faktory $7 D012307
650    _2
$a standardní péče $7 D059039
650    _2
$a komorová tachykardie $x terapie $7 D017180
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Evropa $7 D005060
651    _2
$a Nový Zéland $7 D009520
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Brouwer, Tom F $u Academic Medical Center, Amsterdam, Netherlands.
700    1_
$a Barr, Craig $u Russels Hall Hospital, Dudley, United Kingdom.
700    1_
$a Theuns, Dominic A M J $u Erasmus Medical Centre, Rotterdam, Netherlands.
700    1_
$a Boersma, Lucas V A $u Sint Antonius Hospital, Nieuwegein, Netherlands.
700    1_
$a Johansen, Jens B $u Odense University Hospital, Odense, Denmark.
700    1_
$a Neuzil, Petr $u Na Homolce Hospital, Prague, Czech Republic.
700    1_
$a Wilde, Arthur A M $u Academic Medical Center, Amsterdam, Netherlands.
700    1_
$a Carter, Nathan $u Boston Scientific, St. Paul, MN, USA.
700    1_
$a Husby, Michael $u Boston Scientific, St. Paul, MN, USA.
700    1_
$a Lambiase, Pier D $u The Heart Hospital, London, United Kingdom.
700    1_
$a Knops, Reinoud E $u Academic Medical Center, Amsterdam, Netherlands. Electronic address: r.e.knops@amc.uva.nl.
773    0_
$w MED00002299 $t International journal of cardiology $x 1874-1754 $g Roč. 195, č. - (2015), s. 126-33
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26026928 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160414110252 $b ABA008
999    __
$a ok $b bmc $g 1113571 $s 934510
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 195 $c - $d 126-33 $e 20150522 $i 1874-1754 $m International journal of cardiology $n Int J Cardiol $x MED00002299
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Archiving options